Feedback from the 8th European Bioanalysis Forum Young Scientist Symposium.

EBF Science Café Young Scientist

Journal

Bioanalysis
ISSN: 1757-6199
Titre abrégé: Bioanalysis
Pays: England
ID NLM: 101512484

Informations de publication

Date de publication:
Dec 2022
Historique:
pubmed: 4 2 2023
medline: 4 3 2023
entrez: 3 2 2023
Statut: ppublish

Résumé

After 2 years of COVID-19 restrictions, the 8th Young Scientist Symposium was organized again as a face-to-face meeting covering a broad array of scientific presentations. As in the previous editions, the meeting was organized by young scientists for young scientists under the umbrella of the European Bioanalysis Forum and in collaboration with academia. The traditional Science Café was again included as an interactive round table session. This year, the main focus was on the challenges of communication. New for the 8th edition was a session connecting the young scientists with more seasoned experts in an effort to bridge talent and experience. In this article, we share the feedback of the scientific sessions and the Science Café held at the symposium.

Identifiants

pubmed: 36734458
doi: 10.4155/bio-2022-0232
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1471-1477

Auteurs

Liesl Heughebaert (L)

Laboratory of Toxicology, Ghent University, Ghent, 9000, Belgium.

Adam Williams (A)

Integrated Bioanalysis, Clinical Pharmacology & Safety Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, CB21 6GH, United Kingdom.

Amelia Roberts (A)

Bioanalytical Services, Quotient Sciences, Alnwick, NE66 2DH, United Kingdom.

Cathy Jacobs (C)

Department of Experimental & Clinical Toxicology, Institute of Experimental & Clinical Pharmacology & Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, 66421, Germany.

Claire Szuster (C)

LC-MS Bioanalysis, Drug Development Solutions (part of Alliance Pharma), Fordham, CB7 5WW, United Kingdom.

Connor Walker (C)

Roche Innovation Center Welwyn (contractor), Welwyn Garden City, Hertfordshire, AL7 1TW, United Kingdom (employed by Quotient Sciences, Alnwick, NE66 2DH, United Kingdom, during the meeting).

Elien Van Nuffel (EV)

Bioanalysis & Immunogenicity, DMPK, Sanofi, Zwijnaarde, 9052, Belgium.

Esme Atkin (E)

Bioanalytical Services, ACM Global Laboratories, York, YO10 4DZ, United Kingdom.

Francesca Minelli (F)

R&D, New Biological Entities Drug Metabolism Pharmacokinetics, Innovative BioAnalytics, Merck KGaA, Colleretto Giacosa (TO), 10010, Italy.

Kate Groves (K)

Translational Biomarker & Bioanalysis, UCB Biopharma SRL, Chemin du Foriest 1, Braine-l'Alleud, 1420, Belgium.

Katherine Sime (K)

Charles River Laboratories Edinburgh Ltd, Clearwater House, Research Avenue South, Edinburgh, EH14 4AS, United Kingdom.

Katia Zeiser (K)

Bioanalysis, Nuvisan GmbH, Neu-Ulm, 89231, Germany.

Michele Protti (M)

Research Group of Pharmaco-Toxicological Analysis (PTA Lab), Department of Pharmacy & Biotechnology (FaBiT), Alma Mater Studiorum, University of Bologna, Bologna, 40127, Italy.

Lea Wagmann (L)

Department of Experimental & Clinical Toxicology, Institute of Experimental & Clinical Pharmacology & Toxicology, Center for Molecular Signaling (PZMS), Saarland University, Homburg, 66421, Germany.

Oscar Knight (O)

Intertek Pharmaceutical Services, Manchester, M9 8GQ, United Kingdom.

Robert Stewart (R)

Discovery Bioanalysis, Labcorp Early Development Laboratories Ltd, Harrogate, HG3 1PY, United Kingdom.

Rosie Penford (R)

Bioanalysis, Immunogenicity & Biomarkers, GSK, Stevenage, SG1 2NY, United Kingdom.

Salvatore Calogero (S)

Biochemical Analysis, Swiss BioQuant, Reinach (BL), 4153, Switzerland (employed by F. Hoffmann-La Roche Ltd, Bioanalytical R&D, Regulated Bioanalysis, Basel, 4070, Switzerland, during the meeting).

Philip Timmerman (P)

European Bioanalysis Forum, Havenlaan 86c b204, Brussels, 1000, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH